The effect of antihypertensive drugs on serum magnesium level
DOI:
https://doi.org/10.36320/ajb/v17.i2.19091Keywords:
hypertension, serum magnesium, beta-blocker drugsAbstract
Abstract hypertension is a complicated condition in which many mechanisms collaborate, causing cardiovascular and cerebrovascular implications that are now among the most common causes of death, illness, and medical expenses globally. Currently, 1.13 billion individuals are suffering from hypertension, as reported by the World Health Association. The level of incidence of hypertension rises substantially with age, and due to the continuing aging of the population around the world, both the overall incidence of hypertension and the adverse outcomes continue to keep growing. Some clinical trials and reports suggest that hypertensive individuals possess a deficient serum magnesium level, with reduced levels of magnesium connected to adverse consequences on blood pressure levels. The aim of the study was to evaluate the effect of antihypertensive drugs on serum magnesium levels. The materials and methods of this study include 150 individuals with hypertension who have been recruited in this research from Al-Hakim General Hospital between October 2, 2024, and December 31, 2024. The concentration of magnesium in the patients' serum was determined by the xylidyl blue technique (magnesium liquicolor-human reagent). The results illustrate that patients with hypertension using beta-blocker drugs had significantly low serum magnesium levels. Conclusion: Hypertensive patients taking antihypertensive drugs, particularly beta blockers, had a reduced mean serum magnesium level.
Downloads
References
References
1. Al-Shamma, Y.M.H. and Al-Mudhaffer, Z.A. (2019) ‘The effect of dyslipidemia on pulmonary function test’, Department of Physiology, College of Medicine, University of Kufa. Available at: https://www.researchgate.net/publication/331286782
2. Barragán, R., Llopis, J., Portolés, O., Sorlí, J.V., Coltell, O., Rivas-García, L., Asensio, E.M., Ortega-Azorín, C., Corella, D. and Sánchez-González, C. (2020) ‘Influence of demographic and lifestyle variables on plasma magnesium concentrations and their associations with cardiovascular risk factors in a Mediterranean population’, Nutrients, 12, p. 1018.
3. Brembilla-Perrot, B., de la Chaise, A.T., Le Van, D. and Beurrier, D. (1993) ‘Effect of isoproterenol on serum potassium and magnesium’, European Heart Journal, 14(5), pp. 677-681.
4. Carey, R.M., Muntner, P., Bosworth, H.B. and Whelton, P.K. (2018) ‘Prevention and control of hypertension: JACC health promotion series’, Journal of the American College of Cardiology, 72(11), pp. 1278-1293.
5. DeLalio, L.J., Sved, A.F. and Stocker, S.D. (2020) ‘Sympathetic nervous system contributions to hypertension: updates and therapeutic relevance’, Canadian Journal of Cardiology, 36(5), pp. 712-720.
6. DiNicolantonio, J.J., O’Keefe, J.H. and Wilson, W. (2018) ‘Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis’, Open Heart, 5(1), p. e000668.
7. Dominguez, L.J., Veronese, N. and Barbagallo, M. (2020) ‘Magnesium and hypertension in old age’, Nutrients, 13(1), p. 139.
8. Dos Santos, L.R., Melo, S.R.D.S., Severo, J.S., Morais, J.B.S., da Silva, L.D., de Paiva Sousa, M., de Sousa, T.G.V., Henriques, G.S. and do Nascimento Marreiro, D., 2021. Cardiovascular diseases in obesity: what is the role of magnesium?.
9. Khatami, M.R., Mirchi, E., Khazaeipour, Z., Abdollahi, A. and Jahanmardi, A. (2013) ‘Association between Serum Magnesium and Risk Factors of Cardiovascular Disease in Hemodialysis Patients’, Iranian Journal of Kidney Diseases, 7, pp. 47-52.
10. Liu, A.B., Lin, Y.X., Meng, T.T., Tian, P., Chen, J.L., Zhang, X.H., Xu, W.H., Zhang, Y., Zhang, D., Zheng, Y. and Su, G.H. (2024) ‘Global prevalence and disability-adjusted life years of hypertensive heart disease: A trend analysis from the Global Burden of Disease Study 2019’, Journal of Global Health, 14, p. 04172.
11. Mills, K.T., Stefanescu, A. and He, J. (2020) ‘The global epidemiology of hypertension’, Nature Reviews Nephrology, 16(4), pp. 223-237.
12. Nartea, R., Mitoiu, B.I. and Ghiorghiu, I. (2023) ‘The link between magnesium supplements and statin medication in dyslipidemic patients’, Current Issues in Molecular Biology, 45(4), pp. 3146-3167.
13. Singh, S., Zahoor, I., Sharma, N., Behl, T., Kanojia, N., Sehgal, A., Mohan, S., Almoshari, Y., Salawi, A., Aleya, L., et al. (2022) ‘Insights into the pivotal role of statins and its nanoformulations in hyperlipidemia’, Environmental Science and Pollution Research International, 29, pp. 76514–76531.
14. Sizar, O., Khare, S., Jamil, R.T. and Talati, R. (2022) ‘Statin Medications’, National Library of Medicine. Available at: https://www.ncbi.nlm.nih.gov/books/NBK430940/ (Accessed: 19 February 2023).
15. Tangvoraphonkchai, K. and Davenport, A. (2018) ‘Magnesium and cardiovascular disease’, Advances in Chronic Kidney Disease, 25(3), pp. 251-260.
16. Tibazarwa, K.B. and Damasceno, A.A. (2014) ‘Hypertension in developing countries’, Canadian Journal of Cardiology, 30(5), pp. 527-533.
17. Unger, T., Borghi, C., Charchar, F., Khan, N.A., Poulter, N.R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G.S., Tomaszewski, M. and Wainford, R.D. (2020) ‘2020 International Society of Hypertension global hypertension practice guidelines’, Hypertension, 75(6), pp. 1334-1357.
18. Whyte, K.F., Addis, G.J., Whitesmith, R. and Reid, J.L. (1987) ‘Adrenergic control of plasma magnesium in man’, Clinical Science (London, England: 1979), 72(1), pp. 135-138.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Haneen Alasadi Alshammaa
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
